| Literature DB >> 33918945 |
Piyapong Sirinapakul1, Naesinee Chaiear1,2, Phanumas Krisorn1.
Abstract
The Modified Self-Assessment (MSA) and Present Self-Assessment (PSA) forms are questionnaires used to prioritize the risk of infection of health workers exposed to tuberculosis (TB) in Srinagarind Hospital in Thailand. As MSA was developed from PSA, the validity and reliability of MSA need to be assessed. The research aim is to examine the content validity of MSA and to assess the respective reliability of MSA and PSA vis-à-vis expert opinion. Seven experts determined the content validity index (CVI) of MSA. MSA and PSA were used to prioritize the TB contact of 108 subjects, and we compared the result with the risk assessed by the experts. The respective Kappa agreements between MSA and PSA and the experts were used to assess reliability. The result of the content validity index revealed that MSA had I-CVI > 0.83 for all questions and an S-CVI/Ave above 0.90 for all factors. The Kappa agreement of contact priority between MSA and the experts was 0.80; it was 0.58 between PSA and the experts. MSA can, thus, be used to prioritize contact with tuberculosis in Srinagarind Hospital. MSA is a valid risk communication tool for aerosol-generating procedures. Further study should be conducted in other hospitals, and the number of participants should be increased in order to come to a concrete result.Entities:
Keywords: health worker; reliability; surveillance; tuberculosis; validity
Year: 2021 PMID: 33918945 PMCID: PMC8070430 DOI: 10.3390/ijerph18083981
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Modified Self-Assessment (MSA) form.
| Subject ID…………………..(Identify Index Case: Category 1 ☐ 2 ☐ 3 ☐) Contact Prioritize……….. | |
|---|---|
| Identify Personal Data | |
|
Have you been diagnosed with at least one of the following diseases? | |
| Diabetes mellitus | Systematic lupus erythematosus |
| ☐ Yes ☐ No | |
|
Have you ever had/do you have the health status of at least one of the following conditions? | |
| Smoking (not quit) | Gastrectomy |
| ☐ Yes ☐ No | |
|
Have you used any of the following medication within the last 1 month? | |
| Please identify prescription………………………………………………………………………… | |
|
| |
| ☐ bronchoscopy……………….......……minute(s) | ☐ setting a high-frequency ventilator…minute(s) |
|
| |
| ☐ Isolated room, | ☐ Ward |
Present Self-Assessment (PSA) form.
| Subject ID…………………..(Identify Index Case: Category 1 ☐ 2 ☐ 3 ☐) Contact Prioritize……….. | |||
|---|---|---|---|
|
| |||
|
| |||
| Diabetes mellitus | |||
| ☐ Yes ☐ No | |||
|
| |||
| ☐ bronchoscopy | ☐ chest compression (CPR) | ||
|
| |||
| How long was your contact activity with the TB patient? | |||
| ☐ ≤4 h | ☐ 8–16 h | ☐ 24–50 h | |
|
| |||
| ☐ Operation room | ☐ Recovery room | ||
Figure 1Prioritization of contacts exposed to tuberculosis (TB) Patient Category 1. (Source: OH&S Faculty of Medicine KKU Thailand).
Figure 2Prioritization of contacts exposed to TB Patient Category 2. (Source: OH&S Faculty of Medicine KKU Thailand).
Figure 3Prioritization of contacts exposed to TB Patient Category 3. (Source: OH&S Faculty of Medicine KKU Thailand).
I-CVI and S-CVI/Ave formula and calculation process.
| Personal factors |
| ||||
|
|
|
|
| ||
| HIV | 1 2 3 4 5 6 7 | ||||
| Diabetes mellitus (DM) | 1 2 3 4 5 6 7 | ||||
| End stage renal disease (ESRD) with dialysis | 1 2 3 4 | 5 6 7 | |||
| Chronic obstructive pulmonary disease (COPD) | 1 3 4 5 | 2 6 7 | |||
| Bronchiectasis | 1 | 2 3 4 5 7 | 6 | ||
| Any malignancy/cancer | 1 2 4 | 3 5 6 7 | |||
| Systematic lupus erythematosus (SLE) | 1 2 3 5 7 | 4 6 | |||
| Silicosis | 1 2 3 4 5 6 7 | ||||
| These health statuses are a risk of active TB. | Expert opinion | ||||
| Strongly agree | Agree | Disagree | Strongly disagree | ||
| smoking | 1 2 3 7 | 4 5 6 | |||
| Alcohol abuse | 1 | 2 3 4 5 6 7 | |||
| Old pulmonary TB | 1 2 3 4 7 | 5 6 | |||
| BMI < 18.5 kg/m2 | 1 2 3 4 6 7 | 5 | |||
| Gastrectomy | 1 | 2 3 4 5 6 7 | |||
| Jejunoileal bypass surgery | 1 2 3 4 5 6 7 | ||||
| Renal transplant | 1 2 3 | 4 5 6 7 | |||
| These medications are a risk of active TB | Expert opinion | ||||
| Strongly agree | Agree | Disagree | Strongly disagree | ||
| Corticosteroids ≥15 mg daily for >4 weeks | 1 2 3 4 5 6 7 | ||||
| Multiple cancer chemotherapy agents | 1 2 3 4 5 6 7 | ||||
| Antirejection drugs for organ transplants | 1 2 3 4 5 6 7 | ||||
| Tumor necrosis factor alpha antagonists | 1 2 3 4 5 6 7 | ||||
| Contact activities | These contact activities are at high-risk of latent TB infection | Expert opinion | |||
| Strongly agree | Agree | Disagree | Strongly disagree | ||
| Bronchoscopy | 1 2 3 4 5 6 7 | ||||
| ET-tube intubation | 1 2 3 4 5 6 7 | ||||
| Suction | 1 2 3 4 5 6 7 | ||||
| Autopsy pulmonary TB patient | 1 2 3 4 5 6 | 7 | |||
| Aerosolized medication | 1 3 4 7 | 2 5 6 | |||
| Oxygen therapy ≥3 LPM | 1 3 | 2 4 5 6 7 | |||
| Chest percussion | 1 2 3 4 5 6 7 | ||||
| Sputum collection | 1 2 3 4 5 6 7 | ||||
| Carry sputum (bring sputum container to lab) | 1 2 3 4 5 7 | 6 | |||
| Airway assist using ambu-bag | 1 3 4 | 2 5 6 7 | |||
| Chest compression (CPR) | 1 2 3 4 5 6 7 | ||||
| Sputum examination in laboratory | 5 6 | 1 2 3 4 7 | |||
| Setting a positive pressure ventilator | 1 2 3 4 5 6 7 | ||||
| Setting a high-frequency ventilator | 1 2 3 4 5 6 7 | ||||
| These contact activities are at low risk of latent TB infection | Expert opinion | ||||
| Strongly agree | Agree | Disagree | Strongly disagree | ||
| Oral medication | 1 2 3 4 5 6 7 | ||||
| IV medication | 1 2 3 4 5 6 7 | ||||
| Venous puncture | 1 2 3 4 5 6 7 | ||||
| Cleaning room | 1 2 4 | 3 5 6 | 7 | ||
| Bathing patient in bed | 1 2 3 4 | 5 7 | 6 | ||
| Transferring patient | 1 2 3 4 | 6 7 | 5 | ||
| Vital sign assessment | 1 2 3 4 | 6 7 | 5 | ||
| Talking to the patient | 1 2 3 4 5 6 | 7 | |||
| Environment factors | These rooms are of small size, which carries a high risk of LTBI. | Expert opinion | |||
| Strongly agree | Agree | Disagree | Strongly disagree | ||
| Isolated room | 1 2 3 4 5 6 7 | ||||
| Examination room | 1 2 3 4 | 5 7 | 6 | ||
| Individual room | 1 2 3 | 4 5 7 | 6 | ||
| Bronchoscopy room | 5 6 7 | 1 2 3 | 4 | ||
| Sputum examination room | 5 6 7 | 1 2 3 4 | |||
| Operation room | 1 2 3 4 5 7 | 6 | |||
| X-ray room | 1 2 3 4 5 7 | 6 | |||
| These rooms are of medium size, which carries a medium risk of LTBI | Experts opinion | ||||
| Strongly agree | Agree | Disagree | Strongly disagree | ||
| Intensive care unit (ICU, SICU, CCU) | 1 2 3 4 5 6 7 | ||||
| Ward | 1 2 3 4 5 6 | 7 | |||
| Emergency room | 1 2 3 4 5 6 | 7 | |||
| OPD station | 5 6 7 | 2 3 4 | 1 | ||
| Recovery room | 6 7 | 1 2 4 5 | 3 | ||
| These rooms are of large size, which carries a low risk of LTBI | Experts opinion | ||||
| Strongly agree | agree | disagree | Strongly disagree | ||
| Hall | 1 2 3 4 5 6 7 | ||||
| Large conference room | 1 2 3 4 5 6 7 | ||||
Experts’ identification: 1 = chest medicine doctor; 2, 3, 4 = occupational medicine doctors; 5 = infectious control manager; 6 = safety officer; 7 = epidemiologist. Formula of I-CVI and S-CVI/Ave: I-CVI = (number of experts who “Strongly agree” or “Agree”)/(total nmber of experts). S-CVI/Ave = (total value of I-CVI in the factor)/(number of items in the factor) For example: I-CVI of the bronchiectasis item in personal factors = 6/7 = 0.86; S-CVI/Ave of personal factors = [(1 + 1 + 1 + 1 + 0.86 + 1 + 1 + 1) + (1 + 1 + 1 + 0.86 + 1 + 1 + 1) + (1 + 1+1 + 1)]/19 = 0.99.
Kappa calculation formula and calculation process.
| MSA | Experts | Number of Agreement (%) | PSA | Experts | Number of Agreement (%) |
|---|---|---|---|---|---|
| High | High | 44 (40.7) | High | High | 34 (31.5) |
| High | Medium | 0 | High | Medium | 2 (1.9) |
| High | Low | 6 (5.6) | High | Low | 8 (7.4) |
| Medium | High | 0 | Medium | High | 4 (3.7) |
| Medium | Medium | 4 (3.7) | Medium | Medium | 2 (1.9) |
| Medium | Low | 2 (1.9) | Medium | Low | 1 (0.9) |
| Low | High | 2 (1.9) | Low | High | 8 (7.4) |
| Low | Medium | 2 (1.9) | Low | Medium | 2 (1.9) |
| Low | Low | 48 (44.4) | Low | Low | 47 (43.5) |
| Total agreement | 96 (88.9) | Total agreement | 83 (76.8) | ||
| Kappa (95% CI) | 0.80 (95% CI: 0.70, 0.90) | Kappa (95% CI) | 0.58 (95% CI: 0.44, 0.72) | ||
K = (P0 − P)/(1 − P); SD(K) =; where P0 = proportion of observed agreement; P = proportion of expected agreement. The raw data of contact priority between MSA and the experts and PSA and the experts.
Calculation of agreement of contact priority between MSA and the experts.
| Expert | TI | ||||
|---|---|---|---|---|---|
| High | Medium | Low | |||
|
|
| 44 | 0 | 6 | 50 |
|
| 0 | 4 | 2 | 8 | |
|
| 2 | 2 | 48 | 52 | |
|
| 46 | 8 | 56 | ||
K = ()/() = 0.8; SD(K) = 0.05; 95% CI = K ± Zα/2 SD(K); K ± 1.96 (0.054) = 0.80 ± 0.10; Kappa (95% CI) = 0.80 (0.70, 0.90).
Demographic data of subjects.
| Characteristic | Number (n) | Percentage |
|---|---|---|
| Sex | ||
| Female | 93 | 86.11 |
| Male | 15 | 13.89 |
| Total | 108 | 100 |
| Job title | ||
| Nurses | 55 | 50.93 |
| Nurses’ assistants | 22 | 20.37 |
| Medical technicians | 16 | 14.81 |
| Healthcare assistants | 8 | 7.41 |
| Technicians | 5 | 4.63 |
| Ward workers | 1 | 0.93 |
| Physiotherapists | 1 | 0.93 |
| Total | 108 | 100 |
| Contact workplace | ||
| Inpatient department | 48 | 44.44 |
| Intensive care unit | 25 | 23.15 |
| Laboratory unit | 21 | 19.44 |
| Outpatient department | 11 | 10.19 |
| Operative unit | 3 | 2.78 |
| Total | 108 | 100 |
Content validity of the Modified Self-Assessment (MSA) form.
| Factors | Priorities | Items | I-CVI | S-CVI/Ave | |
|---|---|---|---|---|---|
| Personal | Underlying disease | High risk of aTB | HIV, DM, ESRD with dialysis, silicosis, COPD, cancer, SLE | 1 | 0.99 |
| bronchiectasis | 0.86 | ||||
| Health status | High risk of aTB | smoking, alcohol abuse, old pulmonary TB, gastrectomy, jejunoileal bypass surgery, renal transplant, | 1 | ||
| BMI < 18.5 kg/m2 | 0.86 | ||||
| Medication | High risk of aTB | corticosteroids ≥15 mg daily for >4 weeks, multiple cancer chemotherapy agents, antirejection drugs for organ transplants, tumor necrosis factor alpha antagonists | 1 | ||
| Contact activity | High risk of LTBI | bronchoscopy, ET-tube intubation, suction, aerosolized medication, oxygen therapy ≥3 LPM, chest percussion, sputum collection, airway assist using ambu-bag, chest compression, sputum examination, setting a positive pressure ventilator, setting a high-frequency ventilator | 1 | 0.96 | |
| autopsy, carry sputum | 0.86 | ||||
| Low risk of LTBI | oral medication, IV medication, venous puncture | 1 | |||
| cleaning room, bathing in bed, transferring patient, vital sign assessment, talking to patients | 0.86 | ||||
| Environment | Room size | Small size | isolated room, sputum examination room | 1 | 0.91 |
| examination room, individual room, operation room, bronchoscopy room, X-ray room | 0.86 | ||||
| Medium size | intensive care unit (ICU, SICU, CCU) | 1 | |||
| ward, emergency room, OPD station, recovery room | 0.86 | ||||
| Large size | hall, large conference room | 1 | |||
Kappa agreement of contact priority between MSA and the experts vs. Present Self-Assessment (PSA) and the experts.
| Contact Priority | MSA | Expert | Agreement | PSA | Expert | Agreement |
|---|---|---|---|---|---|---|
| High | 50 | 46 | 44 | 44 | 46 | 34 |
| Moderate | 6 | 6 | 4 | 7 | 6 | 2 |
| Low | 52 | 56 | 48 | 57 | 56 | 47 |
| Total | 108 | 96 | 108 | 83 | ||
| Kappa (95% CI) | 0.80 (95% CI: 0.70, 0.90) | 0.58 (95% CI: 0.44, 0.72) | ||||
Kappa agreement of factors between MSA and the experts vs. PSA and the experts.
| Factors | Priorities | MSA | Expert | Agreement | PSA | Expert | Agreement | |
|---|---|---|---|---|---|---|---|---|
| Personal | Underlying disease | High risk of aTB | 8 | 8 | 7 | 5 | 8 | 4 |
| Low risk of aTB | 100 | 100 | 99 | 103 | 100 | 99 | ||
| Total (n) | 108 | 106 | 108 | 103 | ||||
| Kappa (95% CI) | 0.87 (95% CI: 0.77, 0.96) | 0.59 (95% CI: 0.43, 0.76) | ||||||
| Health status | High risk of aTB | 11 | 7 | 6 | non | 7 | - | |
| Low risk of aTB | 97 | 101 | 96 | non | 101 | - | ||
| Total (n) | 108 | 102 | 108 | - | ||||
| Kappa (95% CI) | 0.64 (95% CI: 0.37, 0.91) | - | ||||||
| Medication | High risk of aTB | 1 | 1 | 1 | non | 1 | - | |
| Low risk of aTB | 107 | 107 | 107 | non | 107 | - | ||
| Total (n) | 108 | 108 | 108 | - | ||||
| Kappa (95% CI) | 1 | - | ||||||
| Contact activity | High risk of LTBI | 42 | 30 | 30 | 33 | 30 | 28 | |
| Low risk of LTBI | 66 | 78 | 66 | 75 | 78 | 73 | ||
| Total (n) | 108 | 96 | 108 | 101 | ||||
| Kappa (95% CI) | 0.75 (95% CI: 0.62, 0.88) | 0.84 (95% CI: 0.73, 0.95) | ||||||
| Environment | Contact duration | ≤4 h | 67 | 72 | 59 | 49 | 72 | 45 |
| 4–8 h | 9 | 15 | 5 | 17 | 15 | 4 | ||
| 8–16 h | 16 | 12 | 8 | 8 | 12 | 3 | ||
| 16–24 h | 8 | 3 | 3 | 8 | 3 | 1 | ||
| 24–50 h | 5 | 1 | 1 | 16 | 1 | 0 | ||
| ≥50 h | 3 | 5 | 2 | 10 | 5 | 0 | ||
| Total (n) | 108 | 78 | 108 | 53 | ||||
| Kappa (95% CI) | 0.50 (95% CI: 0.36, 0.64) | 0.23 (95% CI: 0.13, 0.33) | ||||||
| Room size | Small size | 42 | 45 | 39 | 36 | 45 | 31 | |
| Medium size | 51 | 43 | 38 | 51 | 43 | 33 | ||
| Large size | 15 | 20 | 11 | 21 | 20 | 14 | ||
| Total (n) | 108 | 88 | 108 | 78 | ||||
| Kappa (95% CI) | 0.70 (95% CI: 0.59, 0.81) | 0.56 (95% CI: 0.43, 0.69) | ||||||